Search research articles
Contact Us
Filters
Showing results (381-390 of 388) with videos related to
Page
of 39
Sort By:
You have reached the last page of results.
This site can display upto 388 results.
Hepatology (Baltimore, Md.)
|
November 10, 2025
Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204)
Zhi-Cheng Jin, Jingwei Wei, Yu-Dong Xiao, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
November 27, 2024
Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213)
Zhi-Cheng Jin, Jia-Wei Zhou, Jian-Jian Chen, et al.
Eclinicalmedicine
|
May 15, 2024
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study
Zhi-Cheng Jin, Jian-Jian Chen, Xiao-Li Zhu, et al.
Gut
|
March 30, 2026
Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetes
Yuping Chen, Bingtian Dong, Xinrui Jin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 24, 2010
Toward discovery science of human brain function
Bharat B Biswal, Maarten Mennes, Xi-Nian Zuo, et al.
Liver Cancer
|
October 16, 2018
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)
Jian Zhou, Hui-Chuan Sun, Zheng Wang, et al.
Biomedical and Environmental Sciences : BES
|
January 21, 2021
Association of Overlapped and Un-overlapped Comorbidities with COVID-19 Severity and Treatment Outcomes: A Retrospective Cohort Study from Nine Provinces in China
Yan Ma, Dong Shan Zhu, Ren Bo Chen, et al.
Signal Transduction and Targeted Therapy
|
February 8, 2023
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)
Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang, et al.
Page
of 39
Search research articles
Search
Showing results (381-390 of 388) with videos related to
Sort By:
Page
of 39
You have reached the last page of results.
This site can display upto 388 results.
Hepatology (Baltimore, Md.)
|
November 10, 2025
Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204)
Zhi-Cheng Jin, Jingwei Wei, Yu-Dong Xiao, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
November 27, 2024
Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213)
Zhi-Cheng Jin, Jia-Wei Zhou, Jian-Jian Chen, et al.
Eclinicalmedicine
|
May 15, 2024
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study
Zhi-Cheng Jin, Jian-Jian Chen, Xiao-Li Zhu, et al.
Gut
|
March 30, 2026
Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetes
Yuping Chen, Bingtian Dong, Xinrui Jin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 24, 2010
Toward discovery science of human brain function
Bharat B Biswal, Maarten Mennes, Xi-Nian Zuo, et al.
Liver Cancer
|
October 16, 2018
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)
Jian Zhou, Hui-Chuan Sun, Zheng Wang, et al.
Biomedical and Environmental Sciences : BES
|
January 21, 2021
Association of Overlapped and Un-overlapped Comorbidities with COVID-19 Severity and Treatment Outcomes: A Retrospective Cohort Study from Nine Provinces in China
Yan Ma, Dong Shan Zhu, Ren Bo Chen, et al.
Signal Transduction and Targeted Therapy
|
February 8, 2023
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)
Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang, et al.
Page
of 39